advancements in healthcare sector and growing incidence of neurological disorders are the substantial
driving factors of the market during the forecast period.
Additionally, increasing adoption of neurostimulators is also aiding the growth in the market during the
forecast period. Moreover, increasing demand from developed and developing region is the factors that
likely to create numerous opportunity in the near future.
Global Neurosurgery Software market report covers segmentation analysis of Type, applications And
Region. Type segment of Neurosurgery Software further classifies into Preoperative Planning Software,
Recording Software, Visualization Software, Analysis Software, Others. Report further covers segments
of Application of Neurosurgery Software which includes Functional Neurosurgery, Endoscopic Surgery,
Open Skull Surgery.
The regional analysis of Global Neurosurgery Software Market is considered for the key regions such as
Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the
leading/significant region across the world in terms of market share due to increasing prevalence of
sports injuries and rising prevalence of neurological disorders among people in the region. Europe is
estimated to grow at stable growth rate in the global Neurosurgery Software market over the upcoming
years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period
2019 - 2023 owing to rising aging population and availability of competitively priced surgical imaging
equipment in the region.
Major Players profiled in the Neurosurgery Software Market report incorporate: Renishaw (UK), EMS
Biomedical (Austria), Shimmer (Ireland), Brainlab (Germany), Stryker (USA), Inomed Medizintechnik
(Germany), ELMIKO Medical Equipment (Poland), Touch Surgery (USA), NORAXON (USA), Scopis
(Germany), Lode (Netherlands), Nextech (USA), MEVIS Informatica Medica (Brasil), Compumedics
(Australia), DX-Systems (Ukraine)
Latest Industry News:
Brainlab announced that it has received FDA clearance for Elements Spine SRS and Elements Cranial SRS,
two software applications that aid in the patient-tailored planning of radiosurgery treatments for
indications of the spine and brain. With FDA clearance of these software modules, the Brainlab Elements
portfolio of applications that facilitate quick planning, spare organs at risk, and create highly conformal
radiation doses in the brain and spine is complete and ready for clinical use in the United States.
Request a Discount on standard prices of this premium report @
https://www.businessindustryreports.com/check-discount/167801 .
The objective of the study is to define market sizes of different segments & countries in recent years and
to forecast the values to the coming eight years. The report is designed to incorporate both qualitative
and quantitative aspects of the industry within each of the regions and countries involved in the study.
Furthermore, the report also caters the detailed information about the crucial aspects such as driving
factors & challenges which will define the future growth of the market. Additionally, the report shall also